| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 1 | +23.3K | 8.4% | $3.06 | +$71.4K |
| Sells | 6 | -253K | 91.6% | $5.49 | -$1.39M |
| Net | -5 | -230K | -83.1% | -$1.32M |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Boston Scientific Corp | 10%+ Owner | $19.5M | Jul 13, 2021 | ||
| Glendon E. French III | President and CEO, Director | $4.64M | -$660K | -12.4% | Dec 1, 2025 |
| Derrick Sung | COO and CFO | $2.79M | Dec 1, 2025 | ||
| Steven S. Williamson | PRESIDENT AND CEO, Director | $1.15M | -$244K | -17.6% | Sep 2, 2025 |
| John McKune | Interim Cfo | $690K | Mar 1, 2024 | ||
| Mehul Joshi | Chief Financial Officer & PAO | $670K | -$140K | -17.3% | Sep 2, 2025 |
| Geoffrey Beran Rose | Chief Commercial Officer | $586K | -$83.3K | -12.4% | Dec 1, 2025 |
| David Aaron Lehman | General Counsel | $397K | -$235K | -37.2% | Dec 1, 2025 |
| Alissa Hsu Lynch | Director | $322K | Jun 1, 2023 | ||
| Dana G. Mead Jr. | Director | $175K | Jun 2, 2025 | ||
| Georgia Melenikiotou | Director | $169K | Jun 2, 2025 | ||
| Richard Ferrari | Director | $161K | -$25.3K | -13.6% | Jun 12, 2025 |
| Daniel P. Florin | Director | $159K | +$71.4K | +81.7% | Jun 5, 2025 |
| Tiffany Sullivan | Director | $127K | Jun 2, 2025 | ||
| Thomas William Burns | Director | $124K | Jun 2, 2025 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|